Drugs / Anastozole
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00849030 Comparator | Jul 1996 → Jun 2001 | breast cancer | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anastozole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00849030 ↗ |
| Route | Oral | “1mg, orally, once daily” NCT00849030 ↗ |